Eli Lilly has invested heavily into obesity, dominating the landscape—alongside semaglutide maker Novo Nordisk—with its ...
Irish Examiner on MSN10d
Ireland's small, open economy is about to be put to the testUS president Donald Trump is moving ahead with threatened tariffs and Ireland's food and drink sectors could be a target ...
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. We get into more ...
As we observe World Cancer Day today, let us look at some of the trends in cancer therapeutics expected to improve cancer ...
After 2024, which saw a steady recovery by the life sciences industry, it looks like 2025 is set to be a year of change and ...
Pfizer's oncology business reported strong growth in Q4 as the firm looks ahead to further expansion of its breast cancer and ...
Xaira’s CEO is Marc Tessier-Lavigne, former CSO of Genentech, and the board includes former ... The company’s co-founders are Josh Bilenker, former CEO of Loxo Oncology, a part of Eli Lilly, and ...
Eli Lilly's strong momentum in blockbuster therapies and promising pipeline signals future growth, but competition and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback